Skip to main content
Caplight Logo









TeraDx

TeraDx

Private
ValenciaHealthcare & Life Scienceshttps://teradx.com/

Last Round

Accelerator

Oct 7, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

TeraDx is a biotechnology company that develops microbiome-based diagnostic tools for the early detection of cancer. Its first product is a non-invasive saliva test that uses qPCR analysis and an automated algorithm to identify head and neck cancer in under 24 hours.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

early cancer detectionliquid biopsyhead and neck cancersaliva-based testnon-invasive diagnosticAI diagnosticscancer diagnosticsmicrobial biomarkersdiagnostic algorithmHNSCCmicrobiome diagnosticsoncology diagnosticsqPCR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TeraDx Comparables

Compare TeraDx with similar companies based on industry and business-model similarity.

TeraDx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SummitDX
82%
OrisDX
78%
Roche Holding
61%

TeraDx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 7, 2025

TeraDx Investors

Notable investors and investment history

TeraDx investors
InvestorRounds
Zubi LabsAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 7, 2025

    Led by Zubi Labs

TeraDx Filings

Explore SEC and related filing metadata, where available.

TeraDx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TeraDx's valuation, stock price, and market status.

Is TeraDx a public or private company?

TeraDx is a private company.

What is the current stock price of TeraDx?

TeraDx is a private company with no public stock price. No recent secondary market data is available.

How much is TeraDx worth (valuation)?

Valuation information for TeraDx is not publicly available.

Can I buy TeraDx stock?

TeraDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was TeraDx's last funding round?

TeraDx's most recent funding round was Accelerator on October 7, 2025.

Who are the main investors in TeraDx?

Key investors in TeraDx include Zubi Labs.

Will TeraDx IPO soon?

No public IPO plans have been announced for TeraDx.

How can I track TeraDx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TeraDx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersValencia
Year Founded2025
Last FundingOct 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?